ASCO is one of the world’s leading cancer conferences, where groundbreaking research and treatment advances are discussed. But with so much information coming out at once, it can be hard to know what truly matters. We were grateful to Dr. Kari Hacker, gynecologic oncologist at the UNC Lineberger Comprehensive Cancer Center, for joining our recent webinar where she answered patient questions about the innovation unveiled at ASCO 2026.
During the webinar, we discussed:
- The biggest ovarian cancer headlines from ASCO 2026
- Promising new treatments and clinical trial updates
- What’s new in targeted therapies and immunotherapy
- What these developments could mean for your care
Neither Outcomes4Me nor any participants in or contributors to any webinar, article or content endorses or recommends any products or services. Consult your physician regarding any treatment or therapy.
Personalized support for real care decisions
Understand your diagnosis, explore clinical trials, and track symptoms--all in one place.
Get started
Compare treatments, prepare for appointments, and track side effects—all in the app
Built for your diagnosis, Outcomes4Me gives you the tools to make confident, informed decisions—right when you need them.
Continue in app
